| Interplay of antibody and cytokine production reveals CXCL13 as a potential novel biomarker of lethal SARS-CoV-2 infection AM Horspool, T Kieffer, BP Russ, MA DeJong, MA Wolf, JM Karakiozis, ... Msphere 6 (1), 10.1128/msphere. 01324-20, 2021 | 32 | 2021 |
| Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice MA Wolf, DT Boehm, MA DeJong, TY Wong, E Sen-Kilic, JM Hall, ... Infection and Immunity 89 (3), 10.1128/iai. 00607-20, 2021 | 31 | 2021 |
| CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice MA DeJong, MA Wolf, GJ Bitzer, JM Hall, E Sen-Kilic, JM Blake, JE Petty, ... Vaccine 40 (35), 5229-5240, 2022 | 19 | 2022 |
| Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice KL Weaver, CB Blackwood, AM Horspool, GM Pyles, E Sen-Kilic, ... Frontiers in Immunology 13, 838504, 2022 | 19 | 2022 |
| Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis JM Hall, J Kang, SM Kenney, TY Wong, GJ Bitzer, CO Kelly, CA Kisamore, ... Infection and immunity 89 (12), 2021 | 16 | 2021 |
| Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats JM Hall, GJ Bitzer, MA DeJong, J Kang, TY Wong, MA Wolf, JR Bevere, ... Infection and Immunity 89 (12), 2021 | 13 | 2021 |
| Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice MA Wolf, JM O’Hara, GJ Bitzer, E Narayanan, DT Boehm, JR Bevere, ... npj Vaccines 9 (1), 103, 2024 | 7 | 2024 |
| Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection. mSphere. 2021; 6 AM Horspool, T Kieffer, BP Russ, MA DeJong, MA Wolf, JM Karakiozis, ... Feb 6 (1), 10.1128, 0 | 6 | |
| Long-term analysis of pertussis vaccine immunity uncovers a memory B cell response to whole cell pertussis immunization that is absent from acellular immunized mice KL Weaver, CB Blackwood, AM Horspool, GM Pyles, E Sen-Kilic, ... bioRxiv, 2021.10. 01.462695, 2021 | 3 | 2021 |
| Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge KL Weaver, GJ Bitzer, MA Wolf, GM Pyles, MA DeJong, SR Dublin, ... Plos one 18 (11), e0286925, 2023 | 2 | 2023 |
| Immunization with an mRNA DTP vaccine protects against pertussis in rats GJ Bitzer, NA Fitzgerald, MA DeJong, C Cunningham, JA Chapman, ... Infection and Immunity 92 (8), e00520-23, 2024 | 1 | 2024 |
| BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models MA DeJong, MA Wolf, GJ Bitzer, JM Hall, NA Fitzgerald, GM Pyles, ... Infection and Immunity 92 (3), e00223-23, 2024 | 1 | 2024 |
| Erratum for Wolf et al.,“Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice” MA Wolf, DT Boehm, MA DeJong, TY Wong, E Sen-Kilic, JM Hall, ... Infection and Immunity 89 (10), 2021 | 1 | 2021 |
| The Development of a New Pertussis Booster Formulation via the Implementation of New Adjuvants and Utilization of Alternate Routes of Administration MA DeJong West Virginia University, 2023 | | 2023 |
| Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital AM Horspool, BP Russ, MA Wolf, J Kang, CB Blackwood, JM Hall, ... medRxiv, 2021.08. 16.21262128, 2021 | | 2021 |
| Multivalent mRNA-DTP vaccines are immunogenic and provide protection from MA Wolf, JM O’Hara, GJ Bitzer, E Narayanan, DT Boehm, JR Bevere, ... | | |
